Advertisement

U.S. markets open in 1 hour 51 minutes

S&P Futures
4,064.25
+8.50(+0.21%)
Dow Futures
32,612.00
+12.00(+0.04%)
Nasdaq Futures
12,322.25
+43.00(+0.35%)
Russell 2000 Futures
1,842.40
+6.10(+0.33%)
Crude Oil
113.29
-0.80(-0.70%)
Gold
1,856.30
+8.70(+0.47%)

Advertisement

WEF 2022

Yahoo Finance is in Davos! Get the latest updates here

Else Nutrition Holdings Inc. (0YL.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

0.9650

0.0000

(0.00%)

As of 08:13AM CEST. Market open.

Advertisement

Full screen

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.9650
Open	0.9650
Bid	0.9695 x N/A
Ask	1.0080 x N/A
Day's Range	0.9650 - 0.9650
52 Week Range	0.7380 - 2.1600
Volume	433
Avg. Volume	53

Market Cap	101.665M
Beta (5Y Monthly)	2.15
PE Ratio (TTM)	N/A
EPS (TTM)	-0.1450
Earnings Date	May 16, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 0YL.F

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

GlobeNewswire
Else Produces the World’s First and Only Whole Plant, Soy Free Infant Formula in Advance of FDA Approval
Infant Formula Infant Formula VANCOUVER, British Columbia, May 24, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler, and children nutrition company, announces that it completed initial commercial production in April of its infant formula, to be used in key Clinical Studies for the U.S. market. Following the commercial production, Else will conduct clinical trials to validate product safety and benefits for regula
- US Military Personnel Load Baby Formula Onto Plane at Ramstein Air Base
  Storyful
- KC pediatricians warn parents scrambling to find baby formula: Don’t make your own
  Kansas City Star
ACCESSWIRE
The Power Play by The Market Herald Releases New Interviews with Nextech AR Solutions, Else Nutrition, Banyan Gold, Eat Well Group, and Trillion Energy
VANCOUVER, BC / ACCESSWIRE / May 18, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Nextech AR Solutions, Else Nutrition, Banyan Gold, Eat Well Group, and Trillion Energy on their latest news.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.
GlobeNewswire
Else Nutrition Raises Growth Guidance for Q2oQ1 to 25-38% Amidst the Baby Formula Shortage Crisis
VANCOUVER, British Columbia, May 18, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC (BABY) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler, and children nutrition company, today adjusted guidance for 2Q22 growth projection. 2Q22 Outlook: Else Nutrition expects revenues in the Second Quarter of 2022 to be in the range of $2M to $2.2M, representing a 25% to 38% increase over 1Q22. We are seeing robust preliminary results as a reflection of the deep crisis in the baby